London & Capital Asset Management Ltd Raises Stake in GE HealthCare Technologies Inc. $GEHC

London & Capital Asset Management Ltd increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 102.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 38,271 shares of the company’s stock after buying an additional 19,337 shares during the period. London & Capital Asset Management Ltd’s holdings in GE HealthCare Technologies were worth $2,874,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in GEHC. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at approximately $26,000. E Fund Management Hong Kong Co. Ltd. lifted its stake in GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the last quarter. Allianz SE lifted its stake in GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares during the last quarter. Oakworth Capital Inc. grew its holdings in GE HealthCare Technologies by 1,876.2% during the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after purchasing an additional 394 shares during the period. Finally, Piscataqua Savings Bank increased its position in GE HealthCare Technologies by 173.4% in the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after buying an additional 300 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on GEHC. Jefferies Financial Group boosted their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Evercore increased their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Barclays boosted their price target on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research report on Friday, February 6th. Finally, Morgan Stanley raised their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $92.50.

GE HealthCare Technologies Stock Up 0.4%

GEHC opened at $84.27 on Monday. The firm has a market capitalization of $38.41 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 1.85 and a beta of 1.03. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $90.26. The company has a fifty day moving average price of $82.38 and a 200-day moving average price of $78.46. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter last year, the business posted $1.45 earnings per share. The firm’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.